People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Software / Tech, Biotechnology, Other Technology, Agriculture, Business Services, Lodging and Conventions
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uniphore Technologies Inc. | — | Software / Tech | Series D+ | $594.9M | $7.7B | 2020 |
| Onconova Therapeutics, Inc. | — | Biotechnology | Series C | $124.6M | $137.2M | 2009 |
| Ushur, Inc. | — | Other Technology | Series C | $101.4M | $117.4M | 2018 |
| Versa Networks, Inc. | — | Other Technology | Series C | $89.4M | $1.2B | 2022 |
| Iotium, Inc. | — | Other Technology | Series A | $9.2M | $253.8M | 2018 |
| G2 Developments of Michigan LLC | — | Agriculture | Series A | $5.2M | $1.3M | 2022 |
| KMESH, Inc. | — | Other Technology | Seed | $3.3M | $111.0M | 2019 |
| Valuation Research Corp | — | Business Services | Pre-Seed | $1.9M | $721K | 2020 |
| Ashford Hotel of the Triad, LLC | — | Lodging and Conventions | Pre-Seed | $555K | $4.0M | 2010 |
Pankaj Patel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pankaj Patel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sumant Mandal | 3 | 13 |
| Rajan Raghavan | 2 | 6 |
| ROBERT SCHWARTZ | 1 | 21 |
| Jim Goetz | 1 | 9 |
| Stuart Peterson | 1 | 7 |
| John Chambers | 1 | 6 |
| Michael Webb | 1 | 6 |
| Hilarie Koplow-McAdams | 1 | 5 |
| Werner Cautreels | 1 | 5 |
| Urshit Parikh | 1 | 5 |
| Rob Rueckert | 1 | 5 |
| Chirag Patel | 1 | 4 |
| Meenakshi Singh | 1 | 4 |
| MIKE GOGUEN | 1 | 3 |
| Nikolay Savchuk | 1 | 3 |
| Pradeep Tagare | 1 | 3 |
| Viren Mehta | 1 | 2 |
| Burt Podbere | 1 | 2 |
| APURVA MEHTA | 1 | 2 |
| William J. Hughes | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.